UM School of Medicine Researchers Receive Federal Funding to Rapidly Test New Treatments for COVID-19
AbstractNew release announcing that the University of Maryland School of Medicine will partner with the government's Defense Advanced Research Projects Agency (DARPA) to rapidly test drugs created for other conditions to determine their effectiveness in treating or preventing COVID-19, the disease caused by the SARS-CoV-2 coronavirus.
KeywordCoronavirus Disease 2019 (COVID-19)
Frieman, Matthew B.
Jackson, William T.
Rasko, David A.
Ernst, Robert K.
University of Maryland, Baltimore
University of Maryland, Baltimore. School of Medicine
United States. Defense Advanced Research Projects Agency